Alnylam Pharmaceuticals, Inc. (ALNY)
338.70
+6.02
(+1.81%)
USD |
NASDAQ |
Feb 19, 15:49
Alnylam Pharmaceuticals EPS Diluted (TTM) : 2.257 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Insmed, Inc. | -6.181 |
| Biogen, Inc. | 8.806 |
| Pfizer Inc. | 1.355 |
| Eli Lilly & Co. | 22.59 |
| AbbVie, Inc. | 2.367 |